BeStock  
Stocks › Biotechnology › ASND

Ascendis Pharma A/S ASND

US equityMarket cap rank #681Biotechnology
$227.45 −$0.38 (-0.17%)
Market open · Oct 1, 1:10 pm ET · After hours $227.83 0.00%
Open$228.03
Prev close$227.83
Day range$226.76 – $229.66
Volume395.6K
Market cap$14.97B
P/E (TTM)17.9
Dividend yield–

Analyst view

ConsensusBuy
Analysts18
Average target$317.47+39.6% vs. price
  • Buy 100%
Low $273.00Now $227.45Avg $317.47High $360.00

Recent rating changes

The last 20 actions on file set price targets from $273.00 to $344.00, averaging $306.89.

DateFirmRatingTarget
30 Sep 2026 Barclays BUY $329.00
28 Sep 2026 Morgan Stanley BUY $273.00
25 Sep 2026 Cantor Fitzgerald BUY $300.00
21 Sep 2026 Morgan Stanley BUY $273.00
16 Sep 2026 Wedbush BUY $327.00
16 Sep 2026 H.C. Wainwright BUY $344.00
15 Sep 2026 Raymond James BUY $287.00
15 Sep 2026 BofA Securities BUY $304.00
15 Sep 2026 J.P. Morgan BUY –
14 Sep 2026 Morgan Stanley BUY $273.00
14 Sep 2026 BMO Capital BUY $319.00
10 Sep 2026 H.C. Wainwright BUY $344.00
8 Sep 2026 Morgan Stanley BUY $273.00
2 Sep 2026 Oppenheimer BUY $312.00
1 Sep 2026 Morgan Stanley BUY $273.00
1 Sep 2026 Stifel BUY $326.00
1 Sep 2026 H.C. Wainwright BUY $344.00
31 Aug 2026 Wedbush BUY $327.00
31 Aug 2026 Morgan Stanley BUY $273.00
31 Aug 2026 Jefferies BUY $330.00

Discussion

No comments yet — be the first to weigh in on ASND.

Leave a comment

Scroll to Top